DUBLIN–(BUSINESS WIRE)–The “3D Bioprinting – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global 3D Bioprinting Market to Reach $2.8 Billion by 2027
Amid the COVID-19 crisis, the global market for 3D Bioprinting estimated at US$768.9 Million in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 20.4% over the analysis period 2020-2027.
Living Cells, one of the segments analyzed in the report, is projected to record a 22.6% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hydrogels segment is readjusted to a revised 20.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $228.3 Million, While China is Forecast to Grow at 19.5% CAGR
The 3D Bioprinting market in the U.S. is estimated at US$228.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$479 Million by the year 2027 trailing a CAGR of 19.5% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.5% and 17.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.
Extracellular Matrices Segment to Record 16.6% CAGR
In the global Extracellular Matrices segment, USA, Canada, Japan, China and Europe will drive the 16.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$125.4 Million in the year 2020 will reach a projected size of US$364.2 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$340.2 Million by the year 2027.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS (Total 34 Featured):
3D Bioprinting Solutions 3D Systems Advanced Solutions Life Sciences Allevi Inc. Aspect Biosystems Ltd. Bio3D Technologies Cellink Cellink Global Cyfuse Biomedical K.K. Digilab, Inc. Envisiontec Gesim Inventia Life Science Pty Ltd. Materialise NV Nano3D Biosciences, Inc. Oceanz 3D printing & Additive Manufacturing Organovo Holdings, Inc. Poietis Regemat 3D S.L. Regenhu Regenovo Biotechnology Co., Ltd. Rokit Healthcare Solidscape Stratasys Ltd. Tevido Biodevices Vivax Bio, LLC Voxeljet 3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for 3D Bioprinting by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR World 7-Year Perspective for 3D Bioprinting by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 World Current & Future Analysis for Living Cells by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR World 7-Year Perspective for Hydrogels by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 World Current & Future Analysis for Other Materials by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR World Current & Future Analysis for Biopharmaceutical Companies by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR World 7-Year Perspective for Hospitals by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
Total Companies Profiled: 34 For more information about this report visit https://www.researchandmarkets.com/r/81avbp